THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Peter Johnson to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Peter Johnson has written about Cost-Benefit Analysis.
Peter Johnson
Connection Strength
0.021
Cost-Benefit Analysis
  1. Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. Ann Pharmacother. 2010 Mar; 44(3):447-55.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES